Literature DB >> 27141080

Tumor-Suppressor Functions of the TP53 Pathway.

Brandon J Aubrey1, Andreas Strasser2, Gemma L Kelly2.   

Abstract

The fundamental biological importance of the Tp53 gene family is highlighted by its evolutionary conservation for more than one billion years dating back to the earliest multicellular organisms. The TP53 protein provides essential functions in the cellular response to diverse stresses and safeguards maintenance of genomic integrity, and this is manifest in its critical role in tumor suppression. The importance of Tp53 in tumor prevention is exemplified in human cancer where it is the most frequently detected genetic alteration. This is confirmed in animal models, in which a defective Tp53 gene leads inexorably to cancer development, whereas reinstatement of TP53 function results in regression of established tumors that had been initiated by loss of TP53. Remarkably, despite extensive investigation, the specific mechanisms by which TP53 acts as a tumor suppressor are yet to be fully defined. We review the history and current standing of efforts to understand these mechanisms and how they complement each other in tumor suppression.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27141080      PMCID: PMC4852799          DOI: 10.1101/cshperspect.a026062

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  131 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

Review 3.  p53: traffic cop at the crossroads of DNA repair and recombination.

Authors:  Sagar Sengupta; Curtis C Harris
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

4.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

5.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 6.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

Review 7.  Hallmarks of senescence in carcinogenesis and cancer therapy.

Authors:  Jerry W Shay; Igor B Roninson
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

8.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

9.  Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism.

Authors:  F Galbiati; D Volonté; J Liu; F Capozza; P G Frank; L Zhu; R G Pestell; M P Lisanti
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

10.  Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death.

Authors:  W Gao; Z Shen; L Shang; X Wang
Journal:  Cell Death Differ       Date:  2011-04-08       Impact factor: 15.828

View more
  52 in total

Review 1.  DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

Authors:  Altan Kara; Aykut Özgür; Sinem Nalbantoğlu; Abdullah Karadağ
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

2.  DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.

Authors:  Suet Nee Chen; Raffaella Lombardi; Jennifer Karmouch; Ju-Yun Tsai; Grace Czernuszewicz; Matthew R G Taylor; Luisa Mestroni; Cristian Coarfa; Priyatansh Gurha; Ali J Marian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

3.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

4.  Targeted Sequencing of Tubo-ovarian and Peritoneal High-grade Serous Carcinoma With Wild-type p53 Immunostaining Pattern.

Authors:  Han-Na Kim; Ha Young Woo; Sung-Im DO; Hyun-Soo Kim
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

Review 5.  [Update on Li-Fraumeni syndrome].

Authors:  C M Dutzmann; J Vogel; C P Kratz; K W Pajtler; S M Pfister; B B Dörgeloh
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

6.  The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53.

Authors:  Daniel Menendez; Thuy-Ai Nguyen; Joyce Snipe; Michael A Resnick
Journal:  Mol Cancer Res       Date:  2017-02-23       Impact factor: 5.852

7.  Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis.

Authors:  Mafalda Timóteo; Ana Tavares; Sara Cruz; Carla Campos; Rui Medeiros; Hugo Sousa
Journal:  Biomed Rep       Date:  2021-06-17

8.  Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.

Authors:  Debanjan Dhar; Laura Antonucci; Hayato Nakagawa; Ju Youn Kim; Elisabeth Glitzner; Stefano Caruso; Shabnam Shalapour; Ling Yang; Mark A Valasek; Sooyeon Lee; Kerstin Minnich; Ekihiro Seki; Jan Tuckermann; Maria Sibilia; Jessica Zucman-Rossi; Michael Karin
Journal:  Cancer Cell       Date:  2018-06-11       Impact factor: 31.743

9.  Prognostic significance of the tumor suppressor protein p53 gene in childhood acute lymphoblastic leukemia.

Authors:  Wenwen Weng; Ping Zhang; Jinfei Ruan; Yao Zhang; Diandian Ba; Yongmin Tang
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

Review 10.  Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy.

Authors:  Michail Galanopoulos; Aris Doukatas; Filippos Gkeros; Nikos Viazis; Christos Liatsos
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.